Clinical Research Directory
Browse clinical research sites, groups, and studies.
Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Pancreatic Cancer and Peritoneal Metastasis
Sponsor: Mayo Clinic
Summary
This phase II trial studies the effects of hyperthermic intraperitoneal chemotherapy (HIPEC) in treating patients with pancreatic cancer that has spread to the internal abdominal area (peritoneal metastasis). Chemotherapy drugs, such as nab-paclitaxel and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. HIPEC involves "heated" chemotherapy that is placed directly in the abdomen through laparoscopic instruments, instead of through an intravenous injection. This study may help doctors determine how safe and effective HIPEC work in treating patient with pancreatic cancer.
Official title: A Phase II Study of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Patients With Pancreatic Cancer and Peritoneal Metastasis
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2024-02-15
Completion Date
2029-07
Last Updated
2025-12-16
Healthy Volunteers
No
Conditions
Interventions
Cisplatin
Given via HIPEC
Hyperthermic Intraperitoneal Chemotherapy
Undergo HIPEC with mitomycin and cisplatin
Nab-paclitaxel
Given via HIPEC
Computed Tomography
Undergo CT scan
Magnetic Resonance Imaging
Undergo MRI
Positron Emission Tomography
Undergo PET scan
Locations (1)
Mayo Clinic in Rochester
Rochester, Minnesota, United States